Jincheng Pharm
30023312.821.99% ( +0.25 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Jincheng Pharm(300233) the Revenue is 750.42 M (+3.95%);the EBIT is 85.27 M (+63.11%);the EPS is 0.15 (+66.67%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.75B3.95%
----
----
EBIT
0.09B63.11%
----
----
EPS
0.1566.67%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf